Loading...
Market
Which institution will lead in digital twin tech for cancer treatment by 2025?
2
Resolution / Starting Odds
MIT • 25%
Stanford University • 25%
University of Oxford • 25%
Other • 25%
Research publications and institutional press releases
Story
Researchers Unveil Dual-Drug Nanoparticle Therapy for Cancer Patients; Dostarlimab Cures Colorectal Cancer Without Chemotherapy or Surgery
Dec 24, 2024, 01:14 PM
Researchers have introduced a groundbreaking dual-drug nanoparticle therapy aimed at treating cancer patients. This innovative approach combines phototherapy with chemotherapy, potentially providing a more effective method for combating aggressive tumors while minimizing harsh side effects. The Massachusetts Institute of Technology (MIT) has been at the forefront of this research, highlighting its promise for late-stage cancer patients who typically endure severe treatment regimens. In a related development, the drug Dostarlimab has shown remarkable efficacy in clinical trials for colorectal cancer, curing all patients without the need for chemotherapy or surgery. Additionally, advancements in digital twin technology have led to a method that can revert colon cancer cells to a state resembling normal cells, further reducing side effects associated with traditional cancer treatments.
View original story
Similar markets
Fred Hutch • 25%
Dana-Farber Cancer Institute • 25%
Memorial Sloan Kettering Cancer Center • 25%
Johns Hopkins Kimmel Cancer Center • 25%
AWS • 25%
Deloitte • 25%
Microsoft • 25%
Nvidia • 25%
MIT • 33%
ETH Zurich • 33%
Other collaborating institution • 33%
None • 1%
Yes • 50%
No • 50%
Tulane University • 25%
Other funded research center • 25%
None • 25%
Multiple centers simultaneously • 25%
Kaiser Permanente • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
None of these • 25%
North America • 25%
Europe • 25%
Asia • 25%
Other • 25%
A major pharmaceutical company (e.g., Pfizer, Merck) • 25%
A major tech company (e.g., Google, Microsoft) • 25%
A major hospital network (e.g., Mayo Clinic) • 25%
Other • 25%
Keck School of Medicine at USC • 25%
Cambridge University • 25%
A Canadian Institution • 25%
Other • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
Kaiser Permanente • 25%
Other • 25%
Mayo Clinic • 25%
Cleveland Clinic • 25%
Johns Hopkins Hospital • 25%
Other • 25%
